Literature DB >> 31433319

The Relationship Between Level of Catastrophizing and Mental Health Comorbidity in Individuals With Whiplash Injuries.

Catherine Paré1, Pascal Thibault1, Pierre Côté2, Stephania D Pimentel1, Shiyang Shen1, Esther Yakobov1, Michael J L Sullivan1.   

Abstract

OBJECTIVES: Pain catastrophizing has been shown to be correlated with measures of mental health problems such as depression and post-traumatic stress disorder (PTSD). However, the clinical implications of findings reported to date remain unclear. To date, no study has been conducted to determine meaningful cut-scores on measures of catastrophizing indicative of the heightened risk of mental health comorbidity. One objective of the present study was to identify the cut-score on the Pain Catastrophizing Scale (PCS) indicative of the heightened risk of the comorbidity of depression and PTSD. A second objective was to determine whether mental health comorbidity mediated the relationship between catastrophizing and occupational disability.
MATERIALS AND METHODS: The sample consisted of 143 individuals with whiplash injuries. Pain severity, pain catastrophizing, depression, and post-traumatic stress symptoms were assessed after admission to a rehabilitation program. Mental health comorbidity was operationally defined as obtaining a score above the clinical threshold on measures of depressive and/or post-traumatic stress symptom severity.
RESULTS: A receiver operating characteristic curve analysis revealed that a PCS score of 22 best distinguished between participants with and without mental health comorbidity. Results also revealed that mental health comorbidity mediated the relationship between catastrophizing and occupational disability. DISCUSSION: The findings suggest that a score of ≥22 on the PCS should alert clinicians to the possibility that patients might also be experiencing clinically significant symptoms of depression or PTSD. Greater attention to the detection and treatment of mental health conditions associated with whiplash injury might contribute to more positive recovery outcomes.

Entities:  

Mesh:

Year:  2019        PMID: 31433319     DOI: 10.1097/AJP.0000000000000749

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  6 in total

1.  Self-efficacy beliefs mediate the association between pain intensity and pain interference in acute/subacute whiplash-associated disorders.

Authors:  Yolanda Pedrero-Martin; Deborah Falla; Javier Martinez-Calderon; Bernard X W Liew; Marco Scutari; Alejandro Luque-Suarez
Journal:  Eur Spine J       Date:  2021-01-27       Impact factor: 3.134

2.  The Effect of Pain Catastrophizing on Depression among Older Korean Adults with Chronic Pain: The Mediating Role of Chronic Pain Interference and Sleep Quality.

Authors:  Kyoung-Eun Lee; Hyunju Ryu; Sun Ju Chang
Journal:  Int J Environ Res Public Health       Date:  2020-11-24       Impact factor: 3.390

3.  Artificial intelligence prediction of the effect of rehabilitation in whiplash associated disorder.

Authors:  Alberto Javier Fidalgo-Herrera; María Jesús Martínez-Beltrán; Julio Cesar de la Torre-Montero; José Andrés Moreno-Ruiz; Gabor Barton
Journal:  PLoS One       Date:  2020-12-17       Impact factor: 3.240

4.  Assessment of pain in patients with primary immune deficiency.

Authors:  Maram Al Banyan; Saad Al Shareef; Dina Mahmoud Ahmad Aljayar; Fayha Farraj Abothenain; Agha M Rehan Khaliq; Hassan Alrayes; Rand Arnaout; Farrukh Sheikh
Journal:  Saudi J Anaesth       Date:  2021-04-08

5.  Association of Preexisting Mental Health Conditions With Increased Initial Symptom Count and Severity Score on SCAT5 When Assessing Concussion.

Authors:  Kathryn J Schulze; Michael Robinson; Heather M MacKenzie; James P Dickey
Journal:  Orthop J Sports Med       Date:  2022-09-19

6.  Fear of pain as a predictor of concurrent and downstream PTSD symptoms.

Authors:  Anna C Barbano; Matthew T Tull; Nicole M Christ; Hong Xie; Brian Kaminski; Xin Wang
Journal:  J Anxiety Disord       Date:  2021-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.